Yes, hydrochlorothiazide (HCTZ) is a well-established cause of low sodium levels, a condition called hyponatremia. In one study of 951 outpatients taking a thiazide diuretic, roughly 14% had sodium levels below normal. The risk is particularly high in older adults, where being over 70 was associated with a fourfold increase in hyponatremia compared to younger patients.
How HCTZ Lowers Sodium
HCTZ works by blocking a sodium transporter in the kidneys, specifically in the distal convoluted tubule. Normally, this part of the kidney reabsorbs sodium back into your bloodstream. When HCTZ blocks that process, more sodium gets flushed out in your urine. That’s the whole point of the drug: by losing sodium, you lose water, and your blood pressure drops.
But the drug does something else that compounds the problem. The distal convoluted tubule is also where your kidneys dilute urine, separating excess water from electrolytes. HCTZ interferes with this diluting process, which means your body retains water even as it loses sodium. The combination of increased sodium loss and impaired water excretion is what drives sodium levels down. In some people, HCTZ also triggers the release of antidiuretic hormone, a signal that tells the kidneys to hold onto even more water, further diluting the sodium in your blood.
When It Happens
A meta-analysis in the British Journal of Clinical Pharmacology found that patients presented with thiazide-induced hyponatremia an average of 19 days after starting the medication. The sodium levels at presentation were strikingly low, averaging 116 mEq/L, well into the severe range. Current guidelines recommend checking blood electrolytes one to two weeks after starting a thiazide, but the authors of that review noted this single early check may not be enough, since some cases develop weeks or even months later.
In rare instances, severe hyponatremia has appeared many months or years after starting therapy. This can happen when a new medication is added, dietary habits change, or the body’s ability to handle water shifts with aging or illness. Any new symptoms that could suggest low sodium warrant a blood test, regardless of how long you’ve been on the drug.
Who Is Most at Risk
Three patient characteristics consistently stand out in the research: older age, female sex, and low body weight. In a large international registry comparing patients with thiazide-associated hyponatremia, 52% were 75 or older, and about 71% were women. People with smaller body mass have a lower total body water volume, so even modest shifts in sodium and water balance can produce a significant drop in blood sodium concentration.
Certain medications also amplify the risk. SSRIs (a common class of antidepressants) independently cause the body to release antidiuretic hormone, and when combined with HCTZ, the two drugs can synergistically impair the kidneys’ ability to clear excess water. Case reports have documented severe hyponatremia in patients taking both a thiazide and an SSRI. Other drugs known to lower sodium on their own, including certain anti-seizure medications and nonsteroidal anti-inflammatory drugs, can have a similar compounding effect.
Recognizing the Symptoms
Hyponatremia is classified by severity based on blood sodium levels. Normal sodium is 135 to 145 mEq/L. Mild hyponatremia (130 to 135) often produces no obvious symptoms, or just subtle fatigue and mild nausea that are easy to dismiss. Moderate levels (125 to 129) typically bring on headache, confusion, drowsiness, and irritability. Below 125 mEq/L is considered severe and can cause muscle spasms, seizures, and loss of consciousness.
Because the drop often happens gradually, mild symptoms can creep in without raising alarm. Persistent low energy, mental fogginess, or new-onset nausea in the weeks after starting HCTZ are worth flagging rather than assuming they’re unrelated.
HCTZ Compared to Chlorthalidone
Chlorthalidone, a related thiazide-type diuretic sometimes preferred for its stronger blood pressure effect, carries a higher hyponatremia risk than HCTZ at the same dose. A Dutch population-based study found the odds of hyponatremia were roughly twice as high with chlorthalidone compared to HCTZ at 12.5 mg per day, and about 1.7 times higher at 25 mg per day. The difference largely disappeared when chlorthalidone was compared to double the dose of HCTZ, reflecting chlorthalidone’s greater potency milligram for milligram. If you’ve been switched from HCTZ to chlorthalidone, the risk of sodium imbalance is worth monitoring more closely.
How It Is Managed
The first and most important step is stopping the thiazide or switching to a different type of blood pressure medication. In many cases, sodium levels begin recovering within days once the drug is removed. Fluid restriction is commonly used alongside drug cessation, since the core problem is excess water relative to sodium. Limiting fluid intake helps the kidneys restore a normal sodium-to-water ratio.
For mild cases, stopping the drug and modest fluid restriction are typically all that’s needed. Severe cases, particularly those with neurological symptoms like confusion or seizures, require more urgent correction in a hospital setting. Sodium correction has to be done carefully, because raising levels too quickly can cause its own serious neurological complications.
People who have experienced thiazide-induced hyponatremia once are at high risk of it recurring if they restart the same class of drug. In most cases, an alternative blood pressure medication from a different drug class is a safer long-term choice.